Skip to main content

Ticiana Leal, MD

Ticiana Leal, MD, Winship Cancer Institute
Videos
07/17/2023
At the 2023 ASCO Annual Meeting, Ticiana Leal, MD, discussed the results of the phase 3 LUNAR study, which found that the addition of tumor treating fields to standard of care improved overall survival among patients with metastatic non-small...
At the 2023 ASCO Annual Meeting, Ticiana Leal, MD, discussed the results of the phase 3 LUNAR study, which found that the addition of tumor treating fields to standard of care improved overall survival among patients with metastatic non-small...
At the 2023 ASCO Annual Meeting,...
07/17/2023
Oncology
Ticiana Leal, MD
Videos
09/22/2023
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Ticiana Leal, MD, debated in favor of alectinib over lorlatinib when considering treatment options for patients with ALK-positive non-small cell lung cancer (NSCLC).
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Ticiana Leal, MD, debated in favor of alectinib over lorlatinib when considering treatment options for patients with ALK-positive non-small cell lung cancer (NSCLC).
At the Great Debates & Updates...
09/22/2023
Oncology
Ticiana Leal, MD
Videos
08/21/2024
Ticiana Leal, MD, shares results from her study on anaplastic lymphoma kinase (ALK) testing patterns in patients with early-stage non–small cell lung cancer (NSCLC).
Ticiana Leal, MD, shares results from her study on anaplastic lymphoma kinase (ALK) testing patterns in patients with early-stage non–small cell lung cancer (NSCLC).
Ticiana Leal, MD, shares results...
08/21/2024
Journal of Clinical Pathways